Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems

European Journal of Pharmacology

Volumn 658, Issue 2-3, 2011, Pages 145-149

  Brüning, César Augusto ^a   Souza, Ana Cristina Guerra ^a   Gai, Bibiana Mozzaquatro ^a   Zeni, Gilson ^a   Nogueira, Cristina Wayne ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antidepressant like; Depression; Opioid; Organoselenium; Selenium; Serotonin

Indexed keywords

3 TRIFLUOROMETHYL DIPHENYL DISELENIDE; ANTIDEPRESSANT AGENT; MORPHINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NALOXONE; ONDANSETRON; OPIATE RECEPTOR; ORGANOSELENIUM DERIVATIVE; PAROXETINE; RITANSERIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG STRUCTURE; EXPLORATORY BEHAVIOR; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAPESEED; SEROTONINERGIC SYSTEM;

ANALGESICS, OPIOID; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DRUG INTERACTIONS; FEMALE; MICE; ORGANOSILICON COMPOUNDS; SEROTONIN; SEROTONIN ANTAGONISTS; SWIMMING;

EID: 79953790284     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.02.039     Document Type: Article

References (46)

1. Benton, D., 2002. Selenium intake, mood and other aspects of psychological functioning. Nutr. Neurosci. 5, 363-374.
2. Benton, D., Cook, R., 1991. The impact of selenium supplementation on mood. Biol. Psychiatry 29, 1092-1098.
3. 1A agonists in the treatment of depression. Biol. Psychiatry 53, 193-203.
4. Bodkin, J.A., Zornberg, G.L., Lukas, S.E., Cole, J.O., 1995. Buprenorphine treatment of refractory depression. J. Clin. Psychopharm. 15, 49-57.
5. Brüning, C.A., Prigol, M., Roehrs, J.A., Nogueira, C.W., Zeni, G., 2009. Involvement of the serotonergic system in the anxiolytic-like effect caused by m-trifluoromethyldiphenyl diselenide in mice. Behav. Brain Res. 205, 511-517.
6. Brüning, C.A., Prigol, M., Roehrs, J.A., Zeni, G., Nogueira, C.W., 2010. Evidence for the involvement of mu-opioid and delta-opioid receptors in the antinociceptive effect caused by oral administration of m-trifluoromethyl- diphenyl diselenide in mice. Behav. Pharmacol. 21, 621-626.
7. 2A receptors in depression. J. Psychiatry Neurosci. 29, 252-265.
8. Cryan, J.F., Lucki, I., 2000. Antidepressant-like behavioral effects mediated by 5- hydroxytryptamine 2c receptors. J. Pharmacol. Exp. Ther. 295, 1120-1126.
9. Cryan, J.F., Markou, A., Lucki, I., 2002. Assessing antidepressant activity in rodents: recent developments and future need. TIPS 23, 238-245. (Pubitemid 34465544)
10. Cryan, J.F., Valentino, R.J., Lucki, I., 2005. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. R. 29, 547-569.
11. Darko, D.F., Risch, S.C., Gillin, J.C., Golshan, S., 1992. Association of beta-endorphin with specific clinical symptoms of depression. Am. J. Psychiat. 149, 1162-1167.
12. Devoize, J.L., Rigal, F., Eschalier, A., Trolese, J.F., Renoux, M., 1984. Influence of naloxone on antidepressant drug effects in the forced swimming test in mice. Psychopharmacol. 84, 71-75. (Pubitemid 14032212)
13. Djurovic, D., Milic-Askrabic, J., Majkic-Singh, N., 1999. Serum beta-endorphin level in patients with depression on fluvoxamine. Farmaco 54, 130-133. (Pubitemid 29237558)
14. Duarte, F.S., Martins, P.R.C., Romeiro, G.A., De Lima, T.C.M., 2007. Antidepressant-like profile of action of two 4-amine derivatives of 10,11-dihydro-5 H-dibenzo [a, d] cycloheptane in mice evaluated in the forced swimming test. Bioorgan. Med. Chem. 15, 1645-1650.
15. Duman, R.S., Heninger, O.R., Nestler, E.L., 1997. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54, 597-606.
16. Gay, B.M., Prigol, M., Stein, A.L., Nogueira, C.W., 2010. Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5- diphenylselenophene: involvement of serotonergic system. Neuropharmacology 59, 172-179.
17. Hollister, L.E., Johnson, K., Boukhabza, D., Gillespie, H.K., 1981. Aversive effects of naltrexone in subjects not dependent on opiates. Drug Alcohol Depen. 8, 37-41. (Pubitemid 11004811)
18. Kaster, M.P., Budni, J., Santos, A.R.S., Rodrigues, A.L.S., 2007. Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test. Eur. J. Pharmacol. 576, 91-98.
19. Kennedy, S.E., Koeppe, R.A., Young, E.A., Zubieta, J.K., 2006. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Arch. Gen. Psychiat. 63, 1199-1208.
20. Kreiss, J.D.S., Lucki, I., 1995. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 254, 866-876.
21. Machado, M.S., Rosa, R.M., Dantas, A.S., Reolon, G.K., Appelt, H.R., Braga, A.L., Henriques, J.A.P., Roesler, R., 2006. An organic selenium compound attenuates apomorphine-induced stereotypy in mice. Neurosci. Lett. 410, 198-202.
22. Millan, M.J., 2004. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. Eur. J. Pharmacol. 500, 371-384.
23. Nogueira, C.W., Rocha, J.B.T., 2010. Diphenyl diselenide a Janus-faced molecule. J. Braz. Chem. Soc. 21 (11), 2055-2071.
24. Nutt, D.J., 2008. Relationship of neurotransmitters to the symptoms of major depressive disorder. J. Clin. Psychiat. 69 (Suppl. E1), 4-7.
25. Palucha, A., Pile, A., 2002. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants. Pol. J. Pharmacol. 54, 581-586.
26. Papakostas, G.I., 2006. Dopaminergic-based pharmacotherapies for depression. Eur. Neuropsychopharmacol. 16, 391-402.
27. Paulmier, C., 1986. Selenoorganic functional groups, In: Paulmier, C. (Ed.), Selenium reagents and intermediates in organic synthesis, First ed. Oxford, Pergamon Press, Oxford, pp. 25-51.
28. Petit-Demouliere, B., Chenu, F., Bourin, M., 2005. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 177, 245-255. (Pubitemid 40137284)
29. Porsolt, R.D., Bertin, A., Jalfre, M., 1977a. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Intern. Pharmacodyn. Ther. 299, 327-336.
30. Porsolt, R.D., Le Pichon, M., Jalfre, M., 1977b. Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730-732. (Pubitemid 8073804)
31. Prange Jr., A.J., Wilson, I.C., Lynn, C.W., Alltop, L.B., Stikeleather, R.A., 1974. L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. Arch. Gen. Psychiatry 30, 56-62.
32. Prigol, M., Brüning, C.A., Zeni, G., Nogueira, C.W., 2009a. Protective effect of disubstituted diaryl diselenides on cerebral oxidative damage caused by sodium nitroprusside. Biochem. Eng. J. 45, 94-99.
33. Prigol, M., Schumacher, R.F., Nogueira, C.W., Zeni, G., 2009b. Convulsant effect of diphenyl diselenide in rats and mice and its relationship to plasma levels. Toxicol. Lett. 189, 35-39.
34. Rayman, M.P., 2000. The importance of selenium to human health. Lancet 356, 233-241. (Pubitemid 30446984)
35. Rojas-Corrales, M.O., Berrocoso, E., Gibert-Rahola, J., Mico, J.Á., 2002. Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci. 72, 143-152. (Pubitemid 35363284)
36. 11C] WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry 57, 174-180.
37. Savegnago, L., Jesse, C.R., Pinto, L.G., Rocha, J.B.T., Nogueira, C.W., Zeni, G., 2007. Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats. Prog. Neuro Psychoph. Biol. Psychiatry 31, 1261-1269.
38. Schildkraut, J.J., 1965. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 122 (5), 509-522.
39. Schreiber, S., Bleich, A., Pick, C.G., 2002. Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects-a possible opioid involvement in severe depression? J. Mol. Neurosci. 18, 143-149.
40. Shapira, N.A., Verduin, M.L., DeGraw, J.D., 2001. Treatment of refractory major depression with tramadol monotherapy. J. Clin. Psychiat. 62, 205-206.
41. Stoll, A.L., Rueter, S., 1999. Treatment augmentation with opiates in severe and refractory major depression. Am. J. Psychiat. 156, 2017.
42. Tejedor-Real, P., Micó, J.A., Maldonado, R., Roques, B.P., Gibert-Rahola, J., 1995. Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol. Biochem. Behav. 52, 145-152.
43. Ursini, F., Bindoli, A., 1987. The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem. Phys. Lipids 44, 255-276.
44. Walsh, R.N., Cummins, R.A., 1976. The open-field test: a critical review. Psychol. Bull. 83, 482-504.
45. 2 receptors. Eur. J. Pharmacol. 578, 43-50.
46. Zomkowski, A.D.E., Santos, A.R.S., Rodrigues, A.L.S., 2005. Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci. Lett. 381, 279-283.